NCT00836901View on ClinicalTrials.gov

Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

amoxicillin-clavulanic acid

400 mg-57 mg chewable tablet

DRUG

Augmentin®

400 mg-57 mg chewable tablet

Trial Locations (1)

H3X 2H9

Anapharm Inc., Montreal

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00836901 - Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter